(NYSE: CBT) Cabot's forecast annual revenue growth rate of 0.77% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.08%.
Cabot's revenue in 2023 is $4,321,000,000.On average, 4 Wall Street analysts forecast CBT's revenue for 2023 to be $257,795,526,734, with the lowest CBT revenue forecast at $239,888,194,196, and the highest CBT revenue forecast at $267,092,207,474. On average, 4 Wall Street analysts forecast CBT's revenue for 2024 to be $248,964,572,843, with the lowest CBT revenue forecast at $215,288,826,480, and the highest CBT revenue forecast at $274,054,452,098.
In 2025, CBT is forecast to generate $231,962,163,120 in revenue, with the lowest revenue forecast at $231,962,163,120 and the highest revenue forecast at $231,962,163,120.